Journal Article Summary
The article investigates the effectiveness of inhaled fluticasone, a type of inhaled corticosteroid (ICS), in treating bronchiectasis, a condition characterized by chronic airway inflammation. This topic is important because bronchiectasis can lead to persistent respiratory issues and reduced quality of life for patients. Despite the known inflammation associated with bronchiectasis, there has been limited research on the use of ICS in this patient population, making this study a significant contribution to understanding potential treatment options.
In this study, 86 patients with bronchiectasis were randomly assigned to receive either fluticasone (500 µg twice daily) or a placebo for 12 months. The researchers monitored the patients regularly, and by the end of the study, 35 in the fluticasone group and 38 in the placebo group completed the trial. The results indicated that those receiving fluticasone had a notable improvement in the volume of sputum produced over 24 hours compared to the placebo group. Additionally, patients with Pseudomonas aeruginosa infections showed significant improvements in both sputum volume and the frequency of exacerbations when treated with fluticasone.
However, the study has limitations, including a relatively small sample size and the fact that not all patients completed the trial. While the findings suggest that ICS treatment can be beneficial, especially for those with specific infections, patients should consult their healthcare professionals before making any changes to their treatment plans. It is essential for patients to discuss their individual conditions and treatment options to ensure safe and effective management of bronchiectasis.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Tsang K, Tan K, Ho P, Ooi G, Ho J, Mak J, Tipoe G, Ko C, et al.. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005. DOI: 10.1136/thx.2002.003236. PMID: 15741443. PMCID: PMC1747352.
Featured Pill Pals Product
Fluticasone Propionate 50 mcg Nasal Spray --- Generic for Flonase --- Apotex Pharma
Fluticasone Propionate 50 mcg Nasal Spray — Generic for Flonase — Apotex Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
